久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/11/02 | 5,040 | 5,190 | 5,030 | 5,140 | +165 | +3.3% | 116,900 |
2020/10/30 | 5,050 | 5,050 | 4,955 | 4,975 | -115 | -2.3% | 133,900 |
2020/10/29 | 5,090 | 5,130 | 5,060 | 5,090 | +20 | +0.4% | 62,700 |
2020/10/28 | 4,980 | 5,080 | 4,940 | 5,070 | +40 | +0.8% | 86,700 |
2020/10/27 | 5,030 | 5,030 | 4,955 | 5,030 | -50 | -1% | 62,100 |
2020/10/26 | 5,090 | 5,140 | 5,030 | 5,080 | -50 | -1% | 58,000 |
2020/10/23 | 5,080 | 5,180 | 5,060 | 5,130 | +30 | +0.6% | 71,100 |
2020/10/22 | 5,150 | 5,160 | 5,050 | 5,100 | -120 | -2.3% | 75,000 |
2020/10/21 | 5,160 | 5,250 | 5,140 | 5,220 | +90 | +1.8% | 65,500 |
2020/10/20 | 5,190 | 5,230 | 5,100 | 5,130 | -90 | -1.7% | 81,300 |
2020/10/19 | 5,090 | 5,250 | 5,090 | 5,220 | +150 | +3% | 60,700 |
2020/10/16 | 5,100 | 5,110 | 5,040 | 5,070 | -50 | -1% | 71,600 |
2020/10/15 | 5,190 | 5,250 | 5,110 | 5,120 | -120 | -2.3% | 95,100 |
2020/10/14 | 5,280 | 5,320 | 5,190 | 5,240 | -70 | -1.3% | 95,400 |
2020/10/13 | 5,290 | 5,320 | 5,230 | 5,310 | +40 | +0.8% | 54,500 |
2020/10/12 | 5,350 | 5,420 | 5,230 | 5,270 | -60 | -1.1% | 97,700 |
2020/10/09 | 5,550 | 5,630 | 5,240 | 5,330 | -30 | -0.6% | 159,300 |
2020/10/08 | 5,360 | 5,420 | 5,330 | 5,360 | +60 | +1.1% | 99,200 |
2020/10/07 | 5,330 | 5,350 | 5,190 | 5,300 | -90 | -1.7% | 133,000 |
2020/10/06 | 5,340 | 5,390 | 5,300 | 5,390 | +70 | +1.3% | 104,800 |
2020/10/05 | 5,250 | 5,410 | 5,250 | 5,320 | +130 | +2.5% | 90,000 |
2020/10/02 | 5,330 | 5,350 | 5,130 | 5,190 | - | - | 139,600 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 5,570 | 5,580 | 5,370 | 5,370 | -190 | -3.4% | 124,700 |
2020/09/29 | 5,550 | 5,590 | 5,400 | 5,560 | -20 | -0.4% | 101,900 |
2020/09/28 | 5,520 | 5,580 | 5,450 | 5,580 | +160 | +3% | 134,800 |
2020/09/25 | 5,380 | 5,490 | 5,380 | 5,420 | +40 | +0.7% | 208,900 |
2020/09/24 | 5,400 | 5,440 | 5,360 | 5,380 | -60 | -1.1% | 132,200 |
2020/09/23 | 5,460 | 5,520 | 5,420 | 5,440 | -10 | -0.2% | 110,600 |
2020/09/18 | 5,370 | 5,490 | 5,350 | 5,450 | +100 | +1.9% | 131,200 |
2020/09/17 | 5,320 | 5,370 | 5,280 | 5,350 | +80 | +1.5% | 70,800 |
2020/09/16 | 5,240 | 5,320 | 5,240 | 5,270 | +40 | +0.8% | 60,800 |
2020/09/15 | 5,260 | 5,260 | 5,180 | 5,230 | -60 | -1.1% | 64,800 |
2020/09/14 | 5,230 | 5,360 | 5,230 | 5,290 | +90 | +1.7% | 91,600 |
2020/09/11 | 5,120 | 5,220 | 5,070 | 5,200 | +100 | +2% | 138,700 |
2020/09/10 | 5,030 | 5,120 | 5,020 | 5,100 | +110 | +2.2% | 116,900 |
2020/09/09 | 4,945 | 4,990 | 4,885 | 4,990 | +35 | +0.7% | 145,400 |
2020/09/08 | 4,830 | 4,955 | 4,820 | 4,955 | +130 | +2.7% | 81,900 |
2020/09/07 | 4,825 | 4,845 | 4,800 | 4,825 | +35 | +0.7% | 59,900 |
2020/09/04 | 4,795 | 4,835 | 4,785 | 4,790 | -65 | -1.3% | 56,700 |
2020/09/03 | 4,865 | 4,865 | 4,790 | 4,855 | -10 | -0.2% | 95,000 |
2020/09/02 | 4,845 | 4,870 | 4,770 | 4,865 | +35 | +0.7% | 104,900 |
2020/09/01 | 4,865 | 4,875 | 4,800 | 4,830 | -60 | -1.2% | 85,600 |
2020/08/31 | 4,945 | 5,010 | 4,885 | 4,890 | -65 | -1.3% | 115,300 |
2020/08/28 | 5,030 | 5,080 | 4,900 | 4,955 | -55 | -1.1% | 95,500 |
2020/08/27 | 5,050 | 5,060 | 5,000 | 5,010 | -30 | -0.6% | 110,000 |
2020/08/26 | 5,040 | 5,070 | 5,000 | 5,040 | -40 | -0.8% | 55,300 |
2020/08/25 | 5,180 | 5,190 | 5,030 | 5,080 | -70 | -1.4% | 150,400 |
2020/08/24 | 5,210 | 5,210 | 5,060 | 5,150 | +155 | +3.1% | 242,400 |
2020/08/21 | 5,000 | 5,030 | 4,995 | 4,995 | -5 | -0.1% | 59,900 |
1101~
1150
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム